Sterling Biotech reported net loss of Rs 74.15 crore in the quarter ended December 2011 as against net profit of Rs 22.94 crore during the previous quarter ended December 2010. Sales declined 23.70% to Rs 326.58 crore in the quarter ended December 2011 as against Rs 428.03 crore during the previous quarter ended December 2010.
For the audited full year, net profit declined 86.85% to Rs 19.22 crore in the year ended December 2011 as against Rs 146.21 crore during the previous year ended December 2010. Sales rose 2.81% to Rs 1661.95 crore in the year ended December 2011 as against Rs 1616.58 crore during the previous year ended December 2010.
| Particulars | Quarter Ended | Year Ended |
| | Dec. 2011 | Dec. 2010 | % Var. | Dec. 2011 | Dec. 2010 | % Var. |
| Sales | 326.58 | 428.03 | -24 | 1661.95 | 1616.58 | 3 |
| OPM % | 31.93 | 45.63 | -30 | 38.89 | 43.83 | -11 |
| PBDT | 31.61 | 133.13 | -76 | 375.88 | 479.01 | -22 |
| PBT | -30.26 | 61.30 | PL | 124.70 | 281.39 | -56 |
| NP | -74.15 | 22.94 | PL | 19.22 | 146.21 | -87 |